Cholesterol Ester Transfer Protein in Children on Peritoneal Dialysis

Yuriko Tanaka, Masataka Honda(Rikkyo University), Masahiro Ikeda(Shizuoka University), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Takeshi Matsuyama

Peritoneal Dialysis International

May 1, 2004

10.1177/089686080402400311

Cited by 4

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

|The Lancet|2014|450

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

|Pediatric Nephrology|2022|278

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease

|Clinical and Experimental Nephrology|2013|267

Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies

|Pediatric Nephrology|2021|149

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

|Kidney International|2014|135